The role of barrier genes in epidermal malignancy

被引:29
|
作者
Darido, C. [1 ,2 ,3 ]
Georgy, S. R. [1 ,2 ]
Jane, S. M. [1 ,2 ,4 ]
机构
[1] Alfred Hosp, Dept Med, Epidermal Dev Lab, Prahran, Vic, Australia
[2] Monash Univ, Cent Clin Sch, Prahran, Vic, Australia
[3] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[4] Alfred Hosp, Dept Hematol, Prahran, Vic, Australia
基金
英国医学研究理事会;
关键词
GROWTH-FACTOR RECEPTOR; REGULATES KERATINOCYTE PROLIFERATION; EPITHELIAL STEM-CELLS; NF-KAPPA-B; PERMEABILITY BARRIER; STRATUM-CORNEUM; ALPHA-CATENIN; MICE LACKING; TERMINAL DIFFERENTIATION; ABCA12; MUTATIONS;
D O I
10.1038/onc.2016.84
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The outermost layer of the mammalian skin, the epidermis, forms a protective barrier against pathogenic microbes and tissue dehydration. This barrier is formed and maintained by complex genetic networks that connect cellular differentiation processes, enzymatic activities and cellular junctions. Disruption in these networks affects the balance between keratinocyte proliferation and differentiation resulting in barrier function impairment, epidermal hyperproliferation and in some cases, squamous cell carcinoma (SCC). Recent studies in wound-induced inflammation-mediated cancers in mice have identified dysregulation of core barrier components as tumor drivers. We therefore propose a hypothesis in which loss of key barrier genes, induce barrier dysfunction, and promote inflammation-driven epidermal hyperplasia and carcinogenesis over time. This emerging vision suggests that under specific genetic circumstances, localized barrier impairment could be considered as a hallmark of initiating lesions in epidermal SCC.
引用
收藏
页码:5705 / 5712
页数:8
相关论文
共 50 条
  • [41] Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: Focus on NSCLC
    Langer, CJ
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 58 (03): : 991 - 1002
  • [42] Epidermal barrier disturbances in Rosacea
    Darlenski, R.
    Tsankov, N.
    EXPERIMENTAL DERMATOLOGY, 2012, 21 (09) : E3 - E4
  • [43] Pharmacological Targeting of the Epidermal Barrier
    Kemeny, Lajos
    Nagy, Nikoletta
    Csoma, Zsanett
    Szabo, Kornelia
    Eros, Gabor
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (35) : 5373 - 5381
  • [44] Epidermal barrier disorders in dermatoses
    Proksch, E.
    Daehnhardt, D.
    Daahnhardt-Pfeiffer, S.
    Foelster-Holst, R.
    HAUTARZT, 2016, 67 (11): : 907 - 921
  • [45] Epidermal barrier in disorders of the skin
    Fartasch, M
    MICROSCOPY RESEARCH AND TECHNIQUE, 1997, 38 (04) : 361 - 372
  • [46] The epidermal barrier in atopic dermatitis
    Sugarman, Jeffrey L.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2008, 27 (02) : 108 - 114
  • [47] Bricks and mortar of the epidermal barrier
    Zoltan Nemes
    Peter M Steinert
    Experimental & Molecular Medicine, 1999, 31 : 5 - 19
  • [48] Bricks and mortar of the epidermal barrier
    Nemes, Z
    Steinert, PM
    EXPERIMENTAL AND MOLECULAR MEDICINE, 1999, 31 (01): : 5 - 19
  • [49] LIPIDS AND THE EPIDERMAL PERMEABILITY BARRIER
    ELIAS, PM
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1981, 270 (01) : 95 - 117
  • [50] Epidermal Barrier in Atopic Dermatitis
    Kim, Byung Eui
    Leung, Donald Y. M.
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2012, 4 (01) : 12 - 16